key: cord-0019785-0cqqkpw4 authors: Anyanwu, Madubuike Umunna; Jaja, Ishmael Festus; Oguttu, James Wabwire; Jaja, Chinwe Juliana; Chah, Kennedy Foinkfu; Shodeinde Shoyinka, Vincent title: Is Africa ready for mobile colistin resistance threat? date: 2021-08-04 journal: nan DOI: 10.1080/20008686.2021.1962781 sha: 65588722d0f6773357d459363f9fddf6e1863a07 doc_id: 19785 cord_uid: 0cqqkpw4 Antimicrobial resistance is a growing public health problem and a threat to effective treatment and prevention of an array of infections caused by bacteria. Africa is already faced with many socio-economic and health crises. Many countries in Africa can seldom boast of a standardized health care facility comparable to those in developed countries. Yet, the non-therapeutic use of COL has been banned in developed countries. However, in Africa, except for South Africa, COL is an over-the-counter (OTC) medication sold and dispensed by non-professionals/without a veterinarian’s supervision. The ban of non-therapeutic COL in developed countries has proven to reduce the development of mobile colistin resistance (MCR) in humans and animals. The unregulated use of COL has been proven to select pathogenic and commensal bacteria resistance. A transmissible plasmid-mediated colistin determinant, mobile COL resistance (mcr) gene, which is rapidly transferred/acquired horizontally or laterally intra/inter-species/genera, has been reported. A highly promiscuous mobile genetic element like plasmids containing transposons, insertion sequences, and integrons aid the carriage/rapid transfer and acquisition of these mcr genes. Hence, we highlight the danger posed by escalating colistin (COL) resistance in the continent and the impetus to halt the indiscriminate and non-therapeutic use of COL to protect public health. For many decades, antibiotic has revolutionized healthcare globally, bringing respite to clinicians and veterinarians, especially regarding the treatment of stubborn infections. But the increasing problem of antimicrobial resistance threatens to reverse all the benefits of antibiotics in modern medicine. The damaging impact of antimicrobial resistance (AMR) is already manifesting around the globe. For instance, over 50,000 lives are lost each year across Europe and the US alone, and hundreds of thousands more are dying in other parts of the world [1] . The global estimate of deaths due to AMR stands at 700,000, and it is projected to reach 10 million by the year 2050 [1] . In Africa, deaths attributable to AMR every year by 2050 are estimated to reach 4,150,000 [1] . The projected figure could even be higher in lowand middle-income countries and specifically in Africa, where there is a lack or absence of health infrastructure, poor hospital seeking habit, poor record-keeping, and generally weak or poor governance and regulatory framework. Hence it is time to sound the alarm on the trend and spread of colistin resistance in Africa and the need for every country in the continent to enhance its antibiotics stewardship programs. Colistin (COL) is a polymyxin antibiotic used as a last-line agent for treating deadly infections in humans and animals. COL was discovered in 1947 and isolated in 1950 from the soil bacterium Paenibacillus (Bacillus) polymyxa subspecies colistinus [2] . But its use in human medicine was largely abandoned in the 1970s due to its toxic effects on the kidney and nervous system. However, it continued to be used in the livestock sector in most parts of the world, including inAfrica [3] . However, in the early 2000s, the use of COL in humans was reintroduced due to the rapid rise in deadly infections caused by multi-and extensively-drug resistant organisms [4] . There was a low interest in the COL resistance concept because it was thought that the only mechanism for COL resistance is by mutation in chromosomal genes such as pmrAB, phoPQ, mgrB, and crrAB which are only vertically transferred to bacterial progenies (clones), and thus, by its very nature rare and self-limiting. This perception changed in late 2015 following the discovering of a transmissible plasmidmediated colistin determinant, mobile COL resistance (mcr-1) gene (in Escherichia coli isolates from humans/meats in China), which is rapidly transferred/acquired horizontally/laterally intra/inter species/genera [5] . After the discovery in China, subsequent detection of this plasmid-mediated mechanism was quickly reported worldwide [6] . However, retrospective studies have shown that mcr gene has been in existence since the 1980s. This coinciding with when COL use in livestock began in China but remained undetected [7] . The rapid transfer and acquisition of mcr gene is because they are carried by highly promiscuous mobile genetic elements like plasmids containing transposons, insertion sequences, and integrons. Thus, with mobile colistin resistance (MCR) fast-spreading globally, this poses a considerable threat to antimicrobial therapy, especially in Africa where access to other good quality effective last-line antibiotics is limited. Available evidence shows that these genes have been detected in isolates from all regions of Africa ( Figure 1 ). There are ten mcr gene types (mcr-1 to mcr-10), and of these, include mcr-1 the predominant one, other genes such as mcr-2, mcr-3, mcr-4, mcr-5, mcr-8, and mcr-9. All these have been detected in Africa (Table 1) . These mcr genes evolved and are disseminated by various plasmids such as IncHI2, IncP, IncI, IncX4, IncN, IncR, transposons/insertion sequences (especially ISApl1), and class 1 integrons ( Table 1) . The genes are trafficked by a diversity of bacteria, including predominantly Escherichia coli, Salmonella, Klebsiella, Citrobacter, Enterobacter, Pseudomonas, Acinetobacter, and Alcaligenes faecalis isolated from humans, animals, food of animal origin, and environment [8] [9] [10] [11] . This is not surprising because while COL use in humans is uncommon in Africa, its use in livestock is largely unregulated [12] . Moreover, it has been established that antibiotics induce selective pressure in bacteria prompting them to acquire resistance genes. Thus, there is a high likelihood that in Africa, MCR originated in the veterinary sector from where they disseminated to other ecosystems. Like other drugs in most African countries except for South Africa, COL is an over-thecounter (OTC) medication sold and dispensed by non-professionals/without a veterinarian's supervision. Majority of Africans, including livestock farmers, have poor knowledge about antibiotics and antibiotic resistance. Hence they patronize quacks (non-professionals) and engage in self-medication thereby increasing the problem of resistance. Besides, it is also possible that some of the COL that is sold on the market in these nations are counterfeit or of low quality. Moreover, many antimicrobials used in human and animal medicine in Africa are mostly unregulated [13] . Yet, these nonpolymyxins also facilitate COL resistance [14] . Thus, MCR tends to occur in conjunction with resistance against many other antimicrobial agents, making organisms multi to pandrug resistant. This further leads to limited options for therapy. This situation is exacerbated when an incriminated organism contains mcr and gene coding resistance against other last-resort antimicrobials such as fluoroquinolones, extended-spectrum cephalosporins, fosfomycin, and tigecycline. Unfortunately, such organisms, also referred to as 'superbugs,' have already been isolated from humans [15] , animals [16] , and food of animal origin [17] in Africa. Of noteworthy is that in Africa (Figure 1) , mcr genes (mcr-1 and mcr-2) have been detected in wildlife (terrestrial and aquatic) where antibiotics are not used [18, 19] , thus implying that MCR has disseminated to all ecological niches in Africa. Wildlife in Africa has also been associated with disseminating mcr genes into the environment (surface waters) and the human population [19] . The latter may happen through water used for cooking, laundry, bathing, drinking, and food processing. The genes in the organism from the surface waters could also come from other parts of the world. For example, mcr-1 has been detected in isolates from the sea in Africa [20] . Handling, coming in contact with, and consuming contaminated food of animal origin and fomites, is also a putative source for acquiring mcr genes. Unfortunately, unhygienic animal slaughter techniques are employed in the majority of the slaughterhouses in Africa, and worse still, in Africans, especially those in rural areas, humans live in very close contact with their livestock [21] . Improper disposal of livestock/slaughterhouse wastes into the environment and their use as organic fertilizer in farmlands and aquaculture can spread mcr genes into the environment. For example, mcr-1 has Yes [8, 69] been detected in irrigation and sea waters in Africa [20, 22] . Through the environment, mcr genes are reincorporated into the food chain through contaminated irrigation water, soil, crops, and wildlife [23] . Furthermore, poor personal hygiene, poor waste management, and poor environmental sanitation are prevalent in most African countries and households. This facilitates the spread of mcr genes (Figure 1 ) within the human population and other ecosystems due to practices like open air defecation that are still common in Africa. MCR has an immense One Health ramification in Africa and therefore warrants urgent intervention. With the world gradually turning into 'one village' due to ease of travel between countries and continents, the inability to urgently control the spread of MCR in Africa can potentially result in an outbreak of difficult-to-treat diseases in humans and animals worldwide, which could have catastrophic impacts. The seriousness of this is appreciated when one considers that some of the mcr-harbouring organisms from Africa, especially the E. coli, belong to the highrisk zoonotic pandemic extraintestinal pathogenic E. coli (ExPEC) clones [22, 24, 25] . Furthermore, globally, diseases associated with multidrug-/extensively drug-resistant organisms were recently reported to cause an estimated 700,000 human deaths annually [1] . The question that arises is whether Africa is ready to face a threat posed by MCR in the absence of effective antibiotics that can destroy superbugs. Antimicrobial stewardship (AST) is a proven way to curb antimicrobial resistance. Education of human and animal health workers and the public on prudent/judicious use of antibiotics, conduct of antimicrobial sensitivity test before prescription of antibiotics, and infection prevention and control (IPC) practices like hand hygiene, forms the core of AST program. Unfortunately, Africa is far behind regarding establishing and practicing AST programs [26] . For example, the ban on the non-therapeutic COL has proven to reduce MCR development in humans and animals [27] . But this policy is not yet in view in Africa because weak national drug regulatory authorities characterize most countries in Africa except a few like South Africa, inefficient antibiotic policies, and erratic access to antibiotics [26] . Getting involved in globally-coordinated antimicrobial surveillance programs is needed to control the importation and exportation of mcr genes into/from Africa. Assessing for mcr genes among travelers returning to Africa and quarantine and testing animals imported into the continent is vital to control MCR's spread. The justification for evaluating and testing both travelers and imported animals is not far-fetched. Some mcr-harboring isolates from sick individuals in South Africa were reported to be unrelated to any African strain [28] . The later suggests, that medical tourism could be promoting acquisition of MCR. Furthermore, through the food animal trade route, mcr-1 was imported from France into Tunisia [29] . On the other hand, wild animals captured in Sudan were vectors for exporting mcr-1 to China [30] . Human movement also plays an important role in the spread of mcr-1. For example, Moroccans and Algerians who traveled to Mecca for Hajj pilgrimage imported mcr-1 on returning to their home countries [31] . A citizen of Algeria transported mcr-1 to France [32] . An American and English person who visited Kenya and Egypt, respectively, carried mcr-1 back home [32, 33] , and mcr-1 was detected in isolates from hotel workers in Tanzania that often make contact with foreign tourists [34] . Since as mcr gene has been isolated from sea waters in Africa [20] , it can be carried by water current to other parts of the world. Therefore, efforts need to be stepped up in Africa to control the spread of MCR to preserve the efficacy of COL. In conclusion, mobile COL resistance in Africa is a substantial public health issue with the potential to spread to other continents. However, the continent is not yet ready for this threat. This is a health catastrophe in the making if aggressive efforts to control the development and spread of MCR in Africa are not implemented immediately. No potential conflict of interest was reported by the author(s Antimicrobial Resistance: tackling a crisis for the health and wealth of nations Polymyxins and their potential next generation as therapeutic antibiotics Illustrative examples of probable transfer of resistance determinants from food animals to humans: streptothricins, glycopeptides, and colistin Active surveillance of the spread of mcr-1-positive E coli Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds Early emergence of mcr-1 in Escherichia coli from food-producing animals Identification of mobile colistin resistance genes (mcr-1.1, mcr-5 and mcr-8.1) in Enterobacteriaceae and Alcaligenes faecalis of human and animal origin Resistance to colistin mediated by mcr-1 among multidrug resistant gram negative pathogens at a tertiary care hospital Molecular detection of colistin resistance gene mcr-1 in gram-negative rods isolated from hospitalized patients in khartoum state molecular detection of colistin resistance gene mcr-1 in gram-from hospitalized patients in khartoum state Study of Colistin Resistance Encoded by the mcr-1 Gene in Community and Clinical Pseudomonas in Brazzaville, Republic of Congo Emergence of plasmid-mediated colistin-resistance in CMY-2-producing Escherichia coli of lineage ST2197 in a Tunisian poultry farm Antibiotic use in food animals worldwide, with a focus on Africa: pluses and minuses Letter to the editor: escherichia coli harbouring mcr-1 gene isolated from poultry not exposed to polymyxins in Brazil Emergence of mcr-1 plasmid-mediated colistin-resistant Escherichia coli isolates from seawater Antibiotic resistance in Escherichia coli in husbandry animals: the African perspective Emergence of Escherichia coli harbouring mcr-1 and mcr-3 genes in North West Algerian farmlands Occurrence and Characteristics of Mobile Colistin Resistance (mcr) Gene-Containing Isolates from the Environment: a Review Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages High prevalence of mcr-1 encoding colistin resistance and first identification of blaCTX-M-55 in ESBL/ CMY-2-producing Escherichia coli isolated from chicken faeces and retail meat in Tunisia Treatment of COVID-19: implications for antimicrobial resistance in Africa Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study Emergence of mcr-9.1 in Extended-Spectrum-β-Lactamase-Producing Clinical Enterobacteriaceae in Pretoria Impact of food animal trade on the spread of mcr-1-mediated colistin resistance, tunisia Emergence and Comparative Genomics Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Carrying mcr-1 in Fennec Fox Imported from Sudan to China Acquisition of mcr-1 plasmid-mediated colistin resistance in Escherichia coli and Klebsiella pneumoniae during Hajj Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales Polyclonal gut colonization with extended-spectrum cephalosporinand/or colistin-resistant Enterobacteriaceae: a normal status for hotel employees on the island of Zanzibar High Genetic Diversity of Enterobacteriaceae Clones and Plasmids Disseminating Resistance to Extended-Spectrum Cephalosporins and Colistin in Healthy Chicken in Tunisia High prevalence of extended-spectrum and plasmidic AmpC beta-lactamase-producing Escherichia coli from poultry in Tunisia Various Inc-type plasmids and lineages of Escherichia coli and Klebsiella pneumoniae spreading blaCTX-M-15, blaCTX-M-1 and mcr-1 genes in camels in Tunisia ESBL-and mcr-1-producing Escherichia coli in veal calves in Tunisia Genetic characterization of extended-spectrum β-lactamaseproducing Enterobacteriaceae from a biological industrial wastewater treatment plant in Tunisia with detection of the colistin-resistance mcr-1 gene Dissemination of the mcr-1 colistin resistance gene Colistin Resistance in Enterobacteriaceae Isolated from Humans and Animals in Different Countries Real-time quantitative PCR assay with Taqman® probe for rapid detection of MCR-1 plasmid-mediated colistin resistance Emergence of mcr-1-mediated colistin resistance in Escherichia coli isolates from poultry in Algeria First detected human case in Algeria of mcr-1 plasmid-mediated colistin resistance in a 2011 Escherichia coli isolate First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria Autochthonous case of mobile colistin resistance gene mcr-1 from a uropathogenic Escherichia coli isolate in Sétif Hospital Emergence of plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate from Egypt Prevalence and Some Possible Mechanisms of Colistin Resistance Among Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Genomic Insights into a Colistin-Resistant Uropathogenic Escherichia coli Strain of O23: H4-ST641Lineage Harboring mcr-1.1 on a Conjugative IncHI2 Plasmid from Genomic Features of MCR-1 and Extended-Spectrum β-Lactamase-Producing Enterobacterales from Retail Raw Chicken in Antimicrobial resistance in Enterobacteriaceae from healthy broilers in Egypt: emergence of colistinresistant and extended-spectrum β-lactamaseproducing Escherichia coli 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1108 Detection of colistin encoding resistance genes MCR-1 in isolates recovered from broiler chickens in morocco Genomic features of colistin resistant Escherichia coli ST69 strain harboring mcr-1 on IncHI2 plasmid from raw milk cheese in Egypt Prevalence of colistin-resistant Escherichia coli harbouring mcr-1 in raw beef and ready-to-eat beef products in Egypt Molecular study of colistin resistant clinical isolates of Enterobacteriaceae species Plasmid mediated colistin resistant genes mcr-1 and mcr-2 among Escherichia coli and Klebsiella Pneumoniae isolates at Zagazig University Hospitals, Egypt Real-time NP. PCR for detection of plasmid-mediated polymyxin resistance (mcr-1) from cultured bacteria and stools Colistin resistance gene mcr-1 in avian-pathogenic Escherichia coli in South Africa Extendedspectrum beta-lactamase-producing escherichia coli harbouring mcr-1 gene isolated from pigs in south africa Polymyxins: NP. Antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa Molecular characterization and antimicrobial resistance pattern of Escherichia coli recovered from wastewater treatment plants in Eastern Cape South Africa Characterisation of mcr-4.3 in a colistin-resistant Acinetobacter nosocomialis clinical isolate from Cape Town, South Africa Proteomics analysis of proteins associated with urinary tract infections Colistin Resistance Gene mcr-8 in a High-Risk Sequence Type 15 Klebsiella pneumoniae Isolate from Kenya Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study